Boston Scientific has agreed to buy thrombectomy company Penumbra for about $15 billion in cash and stock in a deal that bolsters its cardiovascular portfolio.
Source link
Boston Scientific to Buy Penumbra for $15 Billion in Cash, Stock
Date:
More like thisRelated
EVERGREY Drop Explosive Single “Architects Of The New Weave” From Upcoming 15th Album
Swedish progressive metal masters Evergrey are ushering in a...
Deutsche Lufthansa Posts In-Line Earnings On Lower Costs, Increased Passengers
Lufthansa said it carried 135 million passengers last year,...
The 2026 ESPN Fantasy Baseball draft guide: Rankings, tips, stats, strategy and more
Whether you are trying fantasy baseball for the first...